Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05172414 · ClinicalTrials.gov registry record
A Novel Fecal Sample Collection Method for Metagenomic Analyses
A clinical trial of Healthy, sponsored by Onegevity Health.
- Completed
- Registry status
- 6
- Enrollment target
- 1
- Study location
NCT05172414: Completed study of Healthy, sponsored by Onegevity Health.
NCT05172414 is a study of Healthy that has completed, run by Onegevity Health. The registered enrollment target is 6 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05172414, a study of Healthy, has completed, sponsored by Onegevity Health.
- COMPLETED
- Registry status
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an open-label, one-arm, one-time-point pilot assessing the intra- and inter-group variation of gut microbiome collection methods and storage conditions using metagenomic sequencing for analysis. This study recruited 6 adult volunteers collecting 12 fecal samples from one bowel movement. Subjects were given detailed instructions as to collect and store feces samples into the 4 different collection and preservation methods and return samples for metagenomic analysis.
Primary Outcome
The primary outcome was is to assess the extent to which our novel approach to fecal sample collection (dissolvable wipe) and stabilization could maintain microbiota composition relative to immediate freezing (-20°C), preservation with a commercially available kit, and storage at room temperature (RT).
Conditions Studied
Interventions
- OTHER No intervention
Study Locations (1)
Maryland
- Center for Integrative Medicine at the University of Maryland School of Medicine - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2020-01-02 |
| Est. Completion | 2021-08-01 |
What the finished NCT05172414 record still lists
NCT05172414 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.
NCT05172414 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT05172414 about?
NCT05172414 is a clinical study titled "A Novel Fecal Sample Collection Method for Metagenomic Analyses". This is an open-label, one-arm, one-time-point pilot assessing the intra- and inter-group variation of gut microbiome collection methods and storage conditions using metagenomic sequencing for analysis. This study recruited 6 adult volunteers collecting 12 fecal samples from one bowel movement. Subj...
What is the current status of trial NCT05172414?
This trial is currently completed. The enrollment target is 6 participants. The study started on 2020-01-02. Estimated completion is 2021-08-01.
What conditions does trial NCT05172414 study?
This clinical trial studies the following conditions: Healthy.
What interventions are being tested in trial NCT05172414?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT05172414?
This trial is sponsored by Onegevity Health, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05172414 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05172414's enrollment target sits among peer trials
6 1075th of 1090 higher than 7 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mapping Auricular Vagus Nerve Circuitry
RECRUITING · Early Phase 1
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
A Study of LY3867070 in Healthy Participants
RECRUITING · Phase 1
-
The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity
RECRUITING
-
Breathing & Blood Pressure
RECRUITING
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI